2023 - Research.com Medicine in Australia Leader Award
His scientific interests lie mostly in Diabetes mellitus, Internal medicine, Endocrinology, Type 2 diabetes and Obesity. Jonathan E. Shaw combines subjects such as Epidemiology, Incidence and Risk factor with his study of Diabetes mellitus. His studies deal with areas such as Gastroenterology and Cross-sectional study as well as Endocrinology.
The various areas that he examines in his Type 2 diabetes study include Randomized controlled trial, Surgery, Glycemic, Insulin resistance and Developing country. His study in Obesity is interdisciplinary in nature, drawing from both Body mass index, Gerontology and Public health. Environmental health, Urbanization and MEDLINE is closely connected to Global health in his research, which is encompassed under the umbrella topic of Gerontology.
His primary areas of investigation include Diabetes mellitus, Internal medicine, Type 2 diabetes, Obesity and Endocrinology. In his study, Cohort study is inextricably linked to Gerontology, which falls within the broad field of Diabetes mellitus. His Internal medicine study integrates concerns from other disciplines, such as Surgery and Cardiology.
The concepts of his Type 2 diabetes study are interwoven with issues in Kidney disease, Intensive care medicine, Type 1 diabetes, Pediatrics and Type 2 Diabetes Mellitus. He has included themes like Body mass index, Epidemiology and Environmental health in his Obesity study. His Body mass index study combines topics from a wide range of disciplines, such as Cross-sectional study, Physical therapy and Cohort.
Jonathan E. Shaw focuses on Diabetes mellitus, Type 2 diabetes, Internal medicine, Obesity and Incidence. Jonathan E. Shaw interconnects Disease, Pediatrics and Kidney disease in the investigation of issues within Diabetes mellitus. His studies in Type 2 diabetes integrate themes in fields like Metformin, Poisson regression, National Death Index, Obstetrics and Gestational diabetes.
His work in Internal medicine addresses issues such as Dulaglutide, which are connected to fields such as Placebo. His Obesity research is multidisciplinary, incorporating perspectives in Body mass index, Logistic regression, Environmental health, Cohort and Australian diabetes. Jonathan E. Shaw combines subjects such as Population Risk, Secular variation and MEDLINE with his study of Incidence.
Jonathan E. Shaw spends much of his time researching Diabetes mellitus, Type 2 diabetes, Internal medicine, Incidence and Obesity. His Diabetes mellitus study incorporates themes from Cause of death, Pediatrics and Age of onset. The Type 2 diabetes study combines topics in areas such as Clinical trial, Poisson regression, Randomized controlled trial, National Death Index and Sulfonylurea.
In his research, Placebo is intimately related to Dulaglutide, which falls under the overarching field of Internal medicine. His Incidence research is multidisciplinary, incorporating elements of Blood lipids, Cholesterol, Absolute risk reduction and Disease. His Obesity study combines topics in areas such as Body mass index, Retrospective cohort study, Cross-sectional study and Australian diabetes.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The metabolic syndrome—a new worldwide definition
K. George M. M. Alberti;Paul Zimmet;Jonathan Shaw.
The Lancet (2005)
Global estimates of the prevalence of diabetes for 2010 and 2030.
J.E. Shaw;R.A. Sicree;P.Z. Zimmet.
Diabetes Research and Clinical Practice (2010)
Global and societal implications of the diabetes epidemic
Paul Zimmet;K. G. M. M. Alberti;Jonathan Shaw.
Metabolic syndrome--a new world-wide definition. A Consensus Statement from the International Diabetes Federation.
K. G. M. M. Alberti;P. Zimmet;J. Shaw.
Diabetic Medicine (2006)
IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040.
Katherine Ogurtsova;J. D. da Rocha Fernandes;Y. Huang;Ute Linnenkamp.
Diabetes Research and Clinical Practice (2011)
Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults
Leandra Abarca-Gómez;Ziad A Abdeen;Zargar Abdul Hamid;Niveen M Abu-Rmeileh.
IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045.
N.H. Cho;N.H. Cho;J.E. Shaw;S. Karuranga;Y. Huang.
Diabetes Research and Clinical Practice (2018)
Global estimates of diabetes prevalence for 2013 and projections for 2035.
L. Guariguata;D.R. Whiting;I. Hambleton;J. Beagley.
Diabetes Research and Clinical Practice (2014)
Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition.
Pouya Saeedi;Inga Petersohn;Paraskevi Salpea;Belma Malanda.
Diabetes Research and Clinical Practice (2019)
Trends in adult body-mass index in 200 countries from 1975 to 2014: A pooled analysis of 1698 population-based measurement studies with 19.2 million participants
Mariachiara Di Cesare;Mariachiara Di Cesare;James Bentham;Gretchen A Stevens;Bin Zhou.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: